HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Choon-Gon Jang Selected Research

ginsenoside Re

12/2017Ginsenoside Re protects against phencyclidine-induced behavioral changes and mitochondrial dysfunction via interactive modulation of glutathione peroxidase-1 and NADPH oxidase in the dorsolateral cortex of mice.
8/2015Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines.
6/2014Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Choon-Gon Jang Research Topics

Disease

14Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 03/2012
13Cognitive Dysfunction
10/2021 - 12/2010
7Neuroblastoma
12/2019 - 04/2011
6Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019 - 12/2009
5Neuroinflammatory Diseases
11/2018 - 01/2016
4Pain (Aches)
07/2022 - 09/2014
4Rheumatoid Arthritis
05/2022 - 03/2017
4Osteoarthritis
05/2022 - 03/2017
4Schizophrenia (Dementia Praecox)
10/2021 - 10/2016
4Parkinson Disease (Parkinson's Disease)
07/2021 - 02/2014
4Sleep Initiation and Maintenance Disorders (Insomnia)
09/2018 - 07/2012
4Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2018 - 02/2012
3Hypertension (High Blood Pressure)
06/2022 - 07/2017
3Hyperthermia
08/2021 - 01/2015
3Neoplasms (Cancer)
12/2019 - 05/2018
3Memory Disorders (Memory Loss)
11/2018 - 12/2009
3Psychotic Disorders (Schizoaffective Disorder)
04/2017 - 11/2006
3Alzheimer Disease (Alzheimer's Disease)
09/2015 - 10/2009
2Heart Failure
06/2022 - 12/2021
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2021 - 11/2012
2Obesity
12/2019 - 05/2018
2Inflammation (Inflammations)
11/2019 - 11/2014
2Substance-Related Disorders (Drug Abuse)
01/2019 - 01/2017
2Overactive Urinary Bladder (Overactive Bladder)
12/2017 - 11/2017
1Lower Urinary Tract Symptoms
11/2021
1Animal Disease Models
10/2021
1Acute Pain
07/2021
1Ankylosing Spondylitis
07/2021
1Drug-Related Side Effects and Adverse Reactions
07/2021
1Dysmenorrhea (Menstrual Pain)
07/2021
1Mood Disorders (Mood Disorder)
03/2021
1Motor Disorders
11/2020
1Mania (Manias)
02/2020
1Hyperpigmentation
11/2019
1Nephritis
11/2019

Drug/Important Bio-Agent (IBA)

7Methamphetamine (Desoxyn)FDA LinkGeneric
07/2021 - 06/2014
7Scopolamine (Hyoscine)FDA Link
08/2019 - 12/2010
6Pharmaceutical PreparationsIBA
05/2022 - 03/2014
5AntioxidantsIBA
08/2019 - 03/2014
5Cholinergic Agents (Cholinergics)IBA
08/2019 - 09/2015
5Cocaine (Cocaine HCl)IBA
01/2019 - 04/2016
4Morphine (MS Contin)FDA LinkGeneric
07/2022 - 09/2014
4Oxidopamine (6 Hydroxydopamine)IBA
12/2019 - 02/2014
4Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2019 - 03/2014
4Glutathione (Reduced Glutathione)IBA
01/2019 - 10/2016
4Phencyclidine (Angel Dust)IBA
11/2018 - 10/2016
3Proteins (Proteins, Gene)FDA Link
03/2021 - 08/2015
3Amyloid (Amyloid Fibrils)IBA
11/2019 - 09/2015
3NADPH Oxidases (NAD(P)H oxidase)IBA
11/2018 - 01/2016
3Protein Kinases (Protein Kinase)IBA
01/2018 - 06/2014
3Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2018 - 02/2012
3ginsenoside ReIBA
12/2017 - 06/2014
3Caspase 3 (Caspase-3)IBA
04/2016 - 03/2012
3Neuroprotective AgentsIBA
06/2015 - 12/2010
2Angiotensin Receptor AntagonistsIBA
12/2021 - 07/2017
2Tamsulosin (Flomax)FDA LinkGeneric
11/2021 - 11/2012
2Adrenergic Receptors (Adrenergic Receptor)IBA
11/2021 - 11/2012
2Dopamine (Intropin)FDA LinkGeneric
08/2021 - 04/2017
2Celecoxib (Celebrex)FDA Link
07/2021 - 03/2017
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
07/2021 - 03/2017
2Cytochrome P-450 CYP2C9IBA
07/2021 - 08/2018
2Therapeutic UsesIBA
03/2021 - 11/2019
26,7,4'-trihydroxyisoflavoneIBA
12/2019 - 05/2018
2daidzeinIBA
12/2019 - 05/2018
2Opioid Analgesics (Opioids)IBA
11/2019 - 12/2018
2LigandsIBA
11/2019 - 01/2012
24- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
11/2018 - 01/2016
2Clozapine (Clozaril)FDA LinkGeneric
11/2018 - 05/2018
2Zolpidem (Ambien)FDA LinkGeneric
08/2018 - 04/2015
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2018 - 08/2015
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2018 - 02/2014
2Tolterodine Tartrate (Detrol)FDA Link
12/2017 - 11/2017
2Muscarinic AntagonistsIBA
12/2017 - 11/2017
2Naloxone (Narcan)FDA LinkGeneric
10/2016 - 09/2009
2gintoninIBA
09/2015 - 01/2012
2NeurotoxinsIBA
07/2014 - 02/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2014 - 03/2014
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
07/2012 - 04/2011
2loganinIBA
03/2011 - 10/2009
1Messenger RNA (mRNA)IBA
07/2022
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
06/2022
1EnzymesIBA
06/2022
1Metoprolol (Toprol-XL)FDA LinkGeneric
06/2022
1Piroxicam (Feldene)FDA LinkGeneric
05/2022
1Meloxicam (Mobic)FDA LinkGeneric
12/2021
1candesartan cilexetil (Amias)FDA Link
12/2021
11- (1- (2- methoxyphenyl)- 2- phenylethyl)piperidineIBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
08/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2021
1AntiemeticsIBA
11/2020
1Metoclopramide (Reglan)FDA LinkGeneric
11/2020
1Superoxide DismutaseIBA
02/2020
1Glutathione PeroxidaseIBA
02/2020
1LithiumIBA
02/2020
1Dextroamphetamine (Dexedrine)FDA LinkGeneric
02/2020
1Valproic Acid (Depakote)FDA LinkGeneric
02/2020

Therapy/Procedure

2Self Administration (Administration, Self)
01/2019 - 12/2018
2Oral Administration
09/2015 - 01/2012
1Precision Medicine
07/2021